P75183 AF NFT

Uncharacterized protein MG414 homolog

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibb7lptlftod4cwxmyi3nvuwgqmqtzme67gg24icjnlzt44mrvobe/metadata.json
IPFS of structure file: 
bafybeidfus3wghvvfka3qzpuhla5rq7pa4nneociyoi3em36n2iq7txtr4/AF-P75183-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x9F605311B7e26e76340423EfAfbE5e2EFc7A0b7C
First NFT owner address (bech32): 
genesis1nas9xydhufh8vdqyy0h6l0j79m785zmurgry0u
Current NFT ID #520188 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
520188
Accession (UniProt):
P75183
Name::
Uncharacterized protein MG414 homolog
Experimental Method:
Predicted structure
Sequence source:
MYCOPLASMA PNEUMONIAE (STRAIN ATCC 29342 / M129)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P75183 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P75183|Y612_MYCPN Uncharacterized protein MG414 homolog OS=Mycoplasma pneumoniae (strain ATCC 29342 / M129) OX=272634 GN=MPN_612 PE=3 SV=1 MRSYHYLPLLGFVAFPTLLANASLDKNLVDSSLYISNSAHHNQGFTVGIKLKDSYFRKDFNFENPLIYKPNNKTTFGWNYSTLWTQLADGYYDRYNQLLRENNFNWYNNIYYIKDVNLGIESSYTSSLAWNKTFSYPGVRNSFKSDIHDLQYFHFHNDSKSGFGPSRINDPWYPQHDKYVTLSAGRTAEEAKNAGWSIPYNLETQRLFSPVWNRNKDFKWINVFFGFMNRSLSVKSPNINDIVQNAKWIKQGKNGNYFIIFNAYAITQNDGFFEDRPNNIFIATLWNNWWLESTPIYIYRVFWEVELIKTPRVFEQDNVQWNEPVLPKETWVFSIDNKQANAYWSSSNGFKDKVIKDRKIMEAFTRNRQVTQSILNMGKNVVVKPLTDDEEQSLFSNKWDIFKYTPIIPVNAQRFGVDFYVEQHNADLKPPISFSQLSRLWLSQLQFDPNSVVDTLSKTFNEKDLSQKDQLQIMFKKEFTQAIAQISKLNEEIDLATDKATALQKFDSLKSKDSNVNFASLQYLYDLLGMEPTNKEHLIFIRNLPEMLQTIFARAKLLAKVKIGDTLQEITLLKNNVNVFDIKTWEKYLTPQQHASNEYTINFLSLDFIVDGYESENLHFQVVDQLFGAVKNLPTINKIPEGYQYKFKYRSNFSNQQFKEKDFSVPLHKAIKSFSVGELKQRMEKLNDFEKQQIVFVIKNSFAGVDKTVLDVDANSLTFVEDPRQYKLDLGNMNENKGFFYVLADIHNSNELFKLGSTIDPEIIKGQIYFVKQNQIKPNTRTYLFKINTRKLLLDKQKLWFKPHLETQTVSFMFDEFEIGKLDIETSNIQLIDDYEFEFQSDFSLQDEQVLLEKLNIVLSQMNLHVETKNARLNPVNKMAYLTVLKNNQKFNLEFHVDRYTSQLSIQAMLGSQRLFAINYDLKLSQNKQMLYLINKDGLEKSVWFNIKNDSQTKLAQQLARFLKENNFQFRQKPVFDFHTQNKAFALEKLDNKDDTD